On April 2, Kasia Lipska, MD, MPH, assistant professor of medicine (endocrinology), testified in Washington before the House Committee on Energy & Commerce Oversight and Investigations Subcommittee on the severe harm that the high price of insulin inflicts on patients, including her own. The venue was a hearing on “Priced Out of a Lifesaving Drug: The Human Impact of Rising Insulin Costs.”